Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Common Stock	Paid-in capital	Retained Earnings Statutory reserves	Retained Earnings Unrestricted	Accumulated other comprehensive income/(loss)	Non-controlling interest	Total
Balance at Mar. 31, 2018	$ 28,937	$ 43,599,089	$ 1,309,109	$ (29,661,190)	$ 3,586,460		$ 18,862,405
Balance, Share at Mar. 31, 2018	28,936,778
Stock based compensation		49,140					49,140
Sale of 10% of Jiuxin Medicine						$ (617,743)	(617,643)
Net loss				(645,852)		(50,763)	(696,615)
Foreign currency translation loss					621,634		621,634
Balance at Jun. 30, 2018	$ 28,937	43,648,229	1,309,109	(30,307,042)	4,208,094	(668,506)	18,218,821
Balance, Shares at Jun. 30, 2018	28,936,778
Balance at Mar. 31, 2018	$ 28,937	43,599,089	1,309,109	(29,661,190)	3,586,460		18,862,405
Balance, Share at Mar. 31, 2018	28,936,778
Net loss							(4,506,297)
Balance at Dec. 31, 2018	$ 28,937	43,747,589	1,309,109	(33,572,688)	2,628,814	(437,342)	13,704,419
Balance, Shares at Dec. 31, 2018	28,936,778
Balance at Jun. 30, 2018	$ 28,937	43,648,229	1,309,109	(30,307,042)	4,208,094	(668,506)	18,218,821
Balance, Share at Jun. 30, 2018	28,936,778
Stock based compensation		49,680					49,680
Stock based compensation, Shares
Net loss				(1,587,414)		(15,298)	(1,602,712)
Foreign currency translation loss					(1,448,661)	48,872	(1,399,789)
Balance at Sep. 30, 2018	$ 28,937	43,697,909	1,309,109	(31,894,456)	2,759,433	(634,932)	15,266,000
Balance, Shares at Sep. 30, 2018	28,936,778
Stock based compensation		49,680					49,680
Net loss				(1,678,232)		(528,736)	(2,206,967)
Foreign currency translation loss					(130,619)	726,326	595,707
Balance at Dec. 31, 2018	$ 28,937	43,747,589	1,309,109	(33,572,688)	2,628,814	(437,342)	13,704,419
Balance, Shares at Dec. 31, 2018	28,936,778
Balance at Mar. 31, 2019	$ 28,937	44,905,664	1,309,109	(30,587,468)	2,508,964	(1,194,039)	18,165,206
Balance, Share at Mar. 31, 2019	28,936,778
Stock based compensation	$ 4,000	34,560					38,560
Stock based compensation, Shares	4,000,008
Financing of subsidiary		9,269,077					9,269,077
Net loss				(2,134,949)		(241,604)	(2,376,553)
Foreign currency translation loss					(405,238)		(405,238)
Balance at Jun. 30, 2019	$ 32,937	54,209,301	1,309,109	(32,722,416)	2,103,726	(1,435,643)	23,497,014
Balance, Shares at Jun. 30, 2019	32,936,786
Balance at Mar. 31, 2019	$ 28,937	44,905,664	1,309,109	(30,587,468)	2,508,964	(1,194,039)	18,165,206
Balance, Share at Mar. 31, 2019	28,936,778
Net loss							(3,269,216)
Balance at Dec. 31, 2019	$ 32,937	54,209,301	1,309,109	(33,415,600)	1,926,259	(1,634,540)	24,062,006
Balance, Shares at Dec. 31, 2019	32,936,786
Balance at Jun. 30, 2019	$ 32,937	54,209,301	1,309,109	(32,722,416)	2,103,726	(1,435,643)	23,497,014
Balance, Share at Jun. 30, 2019	32,936,786
Net loss				(1,224,963)		(122,004)	(1,346,967)
Foreign currency translation loss				(3)	(536,335)	9,708	(526,630)
Balance at Sep. 30, 2019	$ 32,937	54,209,301	1,309,109	(33,947,382)	1,567,391	(1,547,939)	21,623,417
Balance, Shares at Sep. 30, 2019	32,936,786
Net loss				531,782		(75,861)	455,921
Foreign currency translation loss					358,868	(10,740)	348,128
Balance at Dec. 31, 2019	$ 32,937	$ 54,209,301	$ 1,309,109	$ (33,415,600)	$ 1,926,259	$ (1,634,540)	$ 24,062,006
Balance, Shares at Dec. 31, 2019	32,936,786